Off-therapy precipitous HBsAg decline predicts HBsAg loss after finite entecavir therapy in HBeAg-negative patients

Jeng, WJ; Chang, ML; Liaw, YF

Liaw, YF (reprint author), Chang Gung Mem Hosp, Liver Res Unit, 199 Tung Hwa North Rd, Taipei 105, Taiwan.

JOURNAL OF VIRAL HEPATITIS, 2019; 26 (8): 1019

Abstract

Cessation of nucleos(t)ide analogue (Nuc) therapy in HBeAg-negative patients may increase HBsAg loss rate in patients with sustained remission (SR) an......

Full Text Link